References
- Antoku S. Chemical protection of cultured mammalian cells against fast neutrons. International Journal of Radiation Biology 1975; 27: 287–292
- Brander W.T., Hutchinson D.J. Neocarzionstain (NCS-69856): an anti-tumor antibiotic effective against ascitic leukemia L-1210 in mice. Cancer Chemotherapy Report 1966; 55: 79–84
- Chamas R.L., Goldberg J.H. Neocarzinostatin abstracts a hydrogen during formation of nucleotide-5′-aldehyde on DNA. Biochemical and Biophysical Research Communication 1984; 122: 642–648
- DeGraff W.G., Mitchel J.B. Glutathione dependence of neocarzinostatin cytotoxicity and mutagenicity in Chinese hamster V-79 cells. Cancer Research 1985; 45: 4760–4762
- Edo K., Iseki S., Ishida N., Horie T., Kusano G., Nosoe S. An electron spin resonance study of a spin adduct of the non-protein component of neocarzinostatin. Journal of Antibiotics 1980; 33: 1586–1589
- Elkind M.M., Sutton-Gilbert H., Moses W.B., Kamper C. Sub-lethal and lethal radiation damage. Nature 1976; 214: 1088–1092
- Hatayama T., Goldberg I.H., Takeshita M., Grollman A.P. Nucleotide specificity in DNA scission by neocarzinostatin. Biochemistry 1978; 75: 3603–3607
- Ishida N., Miyazaki K., Kumagai K., Rikimaru M. Neocarzinostatin, an antitumor antibiotic of high molecular weight: isolation, physicochemical proteries and biological activities. Journal of Antibiotics, Series A 1965; 18: 68–76
- Ishida R., Nishimoto T., Takahashi T. DNA strand scission by neocarzinostatin and its relation to the inhibition of cell cycle traverse and DNA synthesis. Cell Structure and Function 1979; 4: 235–250
- Kappen L.S., Goldberg I.H. Nitroaromatic radiation sensitizers substitute for oxygen in neocarzinostatin-induced DNA damage. Proceedings of the National Academy of Sciences, USA 1984; 81: 3312–3316
- Kappen L.S., Napier M.A., Goldberg I.H. Role of chromophore and apoprotein in neocarzinostatin action. Proceedings of the National Academy of Sciences, USA 1980; 77: 1970–1974
- Kumagai K., Miyazaki K. The effect of neocarzinostatin on mouse ascites leukemia SN-36. Journal of Antibiotics, Series A 1963; 16: 55–57
- Lawrence T.S. Ouabain sensitizes tumor cells but not normal cells to radiation. International Journal of Radiation Oncology, Biology, Physics 1988; 15: 935–958
- Maeda H., Glaser C.B., Kurozumi K., Meienhofer J. Structure of the antitumor protein neocarzinostatin: amino acid sequence. Archives of Biochemistry and Biophysics 1974; 164: 379–385
- Maeda H., Morinaga T. Augmentation of tumori-tropicity of anticancer agent by increasing molecular weight; and approach by molecular engineering of biopolymer. Igaku no Ayumi, Japan 1983; 124: 25–28
- Maeda H., Takeshita J., Kanamaru R. A lipopholic derivative of neocarzinostatin, a polymer conjugation of an antitumor protein antibiotics. International Journal of Peptide and Protein Research 1979; 14: 81–87
- Nagao T., Kaminura O., Takahashi T., Kitajima K., Hiraki K. The induction chemotherapy of acute leukemia with a new antileukemia agent “neocarzinostatin”. Rinsho Ketsueki (Clinical Hematology), Japan 1973; 14: 925–930
- Nishikawas T., Kumagai K., Kudo A., Ishida N. Cytological study on the effect of neocarzinostatin on sarcoma 180 in vitro. Journal of Antibiotics, Series A 1965; 18: 223–227
- Nolan W.T., Thompson J.E., Lepock J.R., Kruuv J. Effect of membrane lipid perturbers on the temperature of repair of sublethal and potentially lethal radiation damage. International Journal of Radiation Biology 1981; 39: 195–205
- Povirk L.F., Goldberg I.H. Covalent adducts of DNA and the non-protein chromophore of neocarzinostatin contain a modified deoxyribose. Proceedings of the National Academy of Sciences, USA 1982; 79: 369–373
- Rao A.P., Rao P.N. The cause of G2-arrest in Chinese hamster ovary cells treated with anti-cancer drug. Journal of the National Cancer Institute 1976; 57: 1139–1143
- Sakamoto S., Ogata J., Ikegami K., Maeda H. Effects of systemic administration of neocarzinostatin, a new protein antibiotic, on human bladder cancer. Cancer Treatment Reports 1978; 62: 435–454